| abstract |
2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, drugs containing them pharmaceutical compositions, methods of making them, and methods of their use, including methods of treating disease states, disorders, and conditions mediated by JAK, such as inflammatory bowel disease. |